Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $8.2600 (-2.36%) ($8.2600 - $8.2600) on Mon. Dec. 21, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.27% (three month average) | RSI | 87 | Latest Price | $8.2600(-2.36%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.7% a day on average for past five trading days. | Weekly Trend | BCRX advances 18.5% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Rotation from value to growth for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(43%) IBB(38%) IWO(37%) IWC(36%) IWM(36%) | Factors Impacting BCRX price | BCRX will decline at least -2.635% in a week (0% probabilities). VIXM(-19%) UUP(-13%) VXX(-8%) IGOV(-4%) EDOC(-3%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.635% (StdDev 5.27%) | Hourly BBV | -0 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $8.31(-0.6%) | 10 Day Moving Average | $8.09(2.1%) | 20 Day Moving Average | $6.75(22.37%) | To recent high | -3.1% | To recent low | 64.1% | Market Cap | $1.457b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |